{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:37:39Z","timestamp":1762004259074},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,25]],"date-time":"2010-06-25T00:00:00Z","timestamp":1277424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1756-9966-29-82","type":"journal-article","created":{"date-parts":[[2010,6,25]],"date-time":"2010-06-25T18:13:55Z","timestamp":1277489635000},"source":"Crossref","is-referenced-by-count":26,"title":["Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection"],"prefix":"10.1186","volume":"29","author":[{"given":"Safinaz S","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsayed E","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervat M","family":"Hashishe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,25]]},"reference":[{"key":"329_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W","volume":"77","author":"JN Marcus","year":"1996","unstructured":"Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P: Hereditary breast cancer: pathobiology, prognosis, and BRCA1and BRCA2 gene linkage. Cancer. 1996, 77: 697-709. 10.1002\/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W.","journal-title":"Cancer"},{"key":"329_CR2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.26719\/2003.9.3.448","volume":"9","author":"S Omar","year":"2003","unstructured":"Omar S, Khaled H, Gaafar R, Zekry AR, Eissa S, El-Khatib O: Breast cancer in Egypt: a review of disease presentation and detection strategies. Eastern Mediterranean Health Journal. 2003, 9: 448-463.","journal-title":"Eastern Mediterranean Health Journal"},{"key":"329_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/canjclin.47.1.5","volume":"47","author":"SL Parker","year":"1997","unstructured":"Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics. Cancer J Clin. 1997, 47: 5-27. 10.3322\/canjclin.47.1.5.","journal-title":"Cancer J Clin"},{"key":"329_CR4","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jama.1997.03550150046034","volume":"278","author":"D Shattuck-Eidens","year":"1997","unstructured":"Shattuck-Eidens D, Oliphant A, McCuire M, McBride C, Gupte J: BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA. 1997, 278: 1242-1250. 10.1001\/jama.278.15.1242.","journal-title":"JAMA"},{"issue":"Suppl","key":"329_CR5","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8+<1673::AID-CNCR6>3.0.CO;2-B","volume":"86","author":"TR Rebbeck","year":"1999","unstructured":"Rebbeck TR: Inherited genetic predisposition in breast cancer. A population-based perspective. Cancer. 1999, 86 (Suppl): 1673-1681. 10.1002\/(SICI)1097-0142(19991015)86:8+<1673::AID-CNCR6>3.0.CO;2-B.","journal-title":"Cancer"},{"key":"329_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavigian S: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994, 266: 66-71. 10.1126\/science.7545954.","journal-title":"Science"},{"key":"329_CR7","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1126\/science.8091231","volume":"265","author":"R Wooster","year":"1994","unstructured":"Wooster R, Neuhaussen SL, Mangion J, Quick Y, Ford D, Collin N: Localization of a breast cancer susceptibility gene; BRCA2, to chromosome 13q12.i3. Science. 1994, 265: 2088-2090. 10.1126\/science.8091231.","journal-title":"Science"},{"key":"329_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/382678a0","volume":"382","author":"MS Chapman","year":"1996","unstructured":"Chapman MS, Verma IM: Transcriptional activation by BRCA1. Nature. 1996, 382: 678-679. 10.1038\/382678a0.","journal-title":"Nature"},{"key":"329_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0092-8674(00)81847-4","volume":"88","author":"R Scully","year":"1997","unstructured":"Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J: Association of BRCA1 with RaD51 in mitotic and meiotic cells. Cell. 1997, 88: 265-275. 10.1016\/S0092-8674(00)81847-4.","journal-title":"Cell"},{"key":"329_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng0396-333","volume":"12","author":"SV Tavtigian","year":"1996","unstructured":"Tavtigian SV, Simard J, Rommers J, Couch F, Shattuck-Eidens D, Neuhausen S: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet. 1996, 12: 333-337. 10.1038\/ng0396-333.","journal-title":"Nat Genet"},{"key":"329_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1097-2765(00)80276-2","volume":"2","author":"J Chen","year":"1998","unstructured":"Chen J, Silver P, Walpita D, Cantor B, Gazdar F, Tomlinson G: Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol Cell. 1998, 2: 317-328. 10.1016\/S1097-2765(00)80276-2.","journal-title":"Mol Cell"},{"key":"329_CR12","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","volume":"95","author":"K Yoshida","year":"2004","unstructured":"Yoshida K, Miki M: Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 2004, 95: 866-871. 10.1111\/j.1349-7006.2004.tb02195.x.","journal-title":"Cancer Sci"},{"key":"329_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1590\/S1516-31802005000400007","volume":"123","author":"RM Dulfoth","year":"2005","unstructured":"Dulfoth RM, Carvallo S, Heinrich JK, Shinzato JY, Dossantos CC, Zeferino LC: Analysis of BRCAl and BRCA2 mutations in Brazilian breast cancer patients with positive family history. Soo Paulo Med J. 2005, 123: 192-197.","journal-title":"Soo Paulo Med J"},{"key":"329_CR14","doi-asserted-by":"publisher","first-page":"R728","DOI":"10.1186\/bcr1282","volume":"7","author":"P Pohlreich","year":"2005","unstructured":"Pohlreich P, Zikan M, Stribrna J, Kleib Z, Janatova M, Kotlas J: High proportion of recurrent gremline mutations in the BRCAl gene in breast and ovarian cancer patients from the Prague area. Breast cancer research. 2005, 7: R728-R736. 10.1186\/bcr1282.","journal-title":"Breast cancer research"},{"key":"329_CR15","first-page":"678","volume":"52","author":"DF Easton","year":"1993","unstructured":"Easton DF, Bishop T, Ford D, Crockford GP: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet. 1993, 52: 678-701.","journal-title":"Am J Hum Genet"},{"key":"329_CR16","first-page":"1041","volume":"60","author":"T Peelen","year":"1997","unstructured":"Peelen T, Van Vliet M, Petrij-Bosch R: A high proportion of novel mutations in BRCAl with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet. 1997, 60: 1041-1049.","journal-title":"Am J Hum Genet"},{"key":"329_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/(SICI)1098-2264(199702)18:2<126::AID-GCC7>3.0.CO;2-4","volume":"18","author":"U Hamann","year":"1997","unstructured":"Hamann U, Brauch H, Garvin AM, Bastert G, Scott RJ: German family study on hereditary breast and\/or ovarian cancer; germline mutation analysis of the BRCAl gene. Genes chromosomes cancer. 1997, 18: 126-132. 10.1002\/(SICI)1098-2264(199702)18:2<126::AID-GCC7>3.0.CO;2-4.","journal-title":"Genes chromosomes cancer"},{"key":"329_CR18","first-page":"399","volume":"8","author":"S Friedman","year":"1994","unstructured":"Friedman S, Ostermeyer A, Szabo I, Dowd P, Lynch D: Confirmation Of BRCA1 Analysis Of Germline Mutations Linked To Breast And Ovarian Cancer In Ten Families. Naturegenet. 1994, 8: 399-404.","journal-title":"Naturegenet"},{"key":"329_CR19","first-page":"1242","volume":"60","author":"J Ramus","year":"1997b","unstructured":"Ramus J, Kote-Jarai Z, Van Der Looij M, Gayther S, Csokay B, Ponder J: Analysis Of BRCA1 And BRC2 Mutations In Hungarian Families With Breast And Breast- Ovarian Cancer. Amer J Hum Genet. 1997b, 60: 1242-1246.","journal-title":"Amer J Hum Genet"},{"key":"329_CR20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1200\/JCO.1998.16.5.1969","volume":"16","author":"MA Blackwood","year":"1998","unstructured":"Blackwood MA, Weber BL: BRCA1 and BRCA2: from molecular genetics to clinical medicine. J Clin Oncol. 1998, 16: 1969-1977.","journal-title":"J Clin Oncol"},{"key":"329_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/jnci\/95.6.448","volume":"95","author":"GS Dite","year":"2003","unstructured":"Dite GS, Jenkins MA, Southey MC: Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst. 2003, 95: 448-457. 10.1093\/jnci\/95.6.448.","journal-title":"J Natl Cancer Inst"},{"key":"329_CR22","doi-asserted-by":"publisher","first-page":"R175","DOI":"10.1186\/bcr632","volume":"5","author":"N Loman","year":"2003","unstructured":"Loman N, Bladstrom A, Johannsson O, Borg A, Osson H: Cancer incidence in relatives of a population-based set of cases of early- onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast cancer Res. 2003, 5: R175-R186. 10.1186\/bcr632.","journal-title":"Breast cancer Res"},{"key":"329_CR23","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S0140-6736(03)12856-5","volume":"361","author":"F Lallor","year":"2003","unstructured":"Lallor F, Varley J, Ellis P, Moran A, O'Dair L, Pharoah P: The early onset breast cancer study group: Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet. 2003, 361: 1101-1102. 10.1016\/S0140-6736(03)12856-5.","journal-title":"Lancet"},{"key":"329_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<465::AID-IJC5>3.0.CO;2-4","volume":"83","author":"O Diez","year":"1999","unstructured":"Diez O, Cories J, Domenech M, Brunet J, Delrio E, Pericay C: BRCAl mutation analysis in 83 spanish- breast and\/ovarian cancer families. Int J Cancer. 1999, 83: 465-469. 10.1002\/(SICI)1097-0215(19991112)83:4<465::AID-IJC5>3.0.CO;2-4.","journal-title":"Int J Cancer"},{"key":"329_CR25","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S, Coats KH, Swisher E, Stray SM: Spectrum of Mutations in BRCAl, CHEK2 and TP53 in families at high risk of breast cancer. JAMA. 2006, 295: 1379-1388. 10.1001\/jama.295.12.1379.","journal-title":"JAMA"},{"issue":"Suppl 11","key":"329_CR26","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2575::AID-CNCR15>3.0.CO;2-F","volume":"86","author":"SL Neuhausen","year":"1999","unstructured":"Neuhausen SL: Ethnic differences in cancer risk resulting from genetic variation. Cancer. 1999, 86 (Suppl 11): 2575-2582. 10.1002\/(SICI)1097-0142(19991201)86:11+<2575::AID-CNCR15>3.0.CO;2-F.","journal-title":"Cancer"},{"key":"329_CR27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0959-8049(99)00050-7","volume":"35","author":"A Dorum","year":"1999","unstructured":"Dorum A, Hovig E, Trope C, Inganas M, Moller P: Three percent of Norwegian ovarian cancers are caused by BRCAl 1675 del A or 1135 ins A. Eur J Cancer. 1999, 35: 779-781. 10.1016\/S0959-8049(99)00050-7.","journal-title":"Eur J Cancer"},{"key":"329_CR28","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/ijc.10194","volume":"98","author":"ML DeLeon","year":"2002","unstructured":"DeLeon ML, Liede A, Kwan E, Mapua CA, Cutiongeo EM, Tun A: BRCAl and BRCA2 mutations among breast cancer patients from the Philippines. Int J Cancer. 2002, 98: 596-603. 10.1002\/ijc.10194.","journal-title":"Int J Cancer"},{"key":"329_CR29","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1086\/342506","volume":"71","author":"A Liede","year":"2002","unstructured":"Liede A, Malik IA, Aziz Z, Rios P, Kwan E, Narod SA: Contribution of BRCAl and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet. 2002, 71: 595-606. 10.1086\/342506.","journal-title":"Am J Hum Genet"},{"key":"329_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/humu.10154","volume":"20","author":"A Lied","year":"2002","unstructured":"Lied A, Narod SA: Hereditary breast and ovarian cancer in Asia: Genetic epidemiology of BRCA1 and BRCA2. Human Mutation. 2002, 20: 413-424. 10.1002\/humu.10154.","journal-title":"Human Mutation"},{"key":"329_CR31","first-page":"304","volume":"36","author":"G Goelen","year":"1999","unstructured":"Goelen G, Teugels E, Bonduelle M, Neyns B, DeGreive J: High frequency of BRCA1\/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects. J Med Genet. 1999, 36: 304-308.","journal-title":"J Med Genet"},{"key":"329_CR32","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1086\/302922","volume":"66","author":"B Corski","year":"2000","unstructured":"Corski B, Byrski T, Huzarski T, Jakubowska A: Founder mutations in the BRCA1 gene in polish families with breast-ovarian cancer. Am J Hum Genet. 2000, 66: 1963-1968. 10.1086\/302922.","journal-title":"Am J Hum Genet"},{"key":"329_CR33","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/hmg\/7.5.801","volume":"7","author":"RB Bar-Sade","year":"1998","unstructured":"Bar-Sade RB, Kruglikova A, MoDan B, Gak E: The 185 del AG BRCA1 mutation originated before the dispersion of Jews in the Diaspora and is not limited to Ashkenazim. Hum Mol Genet. 1998, 7: 801-805. 10.1093\/hmg\/7.5.801.","journal-title":"Hum Mol Genet"},{"key":"329_CR34","first-page":"153","volume":"123","author":"A Osorio","year":"1998","unstructured":"Osorio A, Robledo M, Albertos J, Diez O: Molecular analysis of the six most recurrent mutations in the BRCA1 gene in 87 Spanish breast\/ovarian cancer families. Cancer. 1998, 123: 153-158.","journal-title":"Cancer"},{"key":"329_CR35","first-page":"1021","volume":"60","author":"D Stoppa","year":"1997","unstructured":"Stoppa D, Laurent P, Essioux L, Pages S: BRCA1 sequence variations in 160 individuals referred to a breast\/ovarian family cancer clinic. Am J Hum Genet. 1997, 60: 1021-1030.","journal-title":"Am J Hum Genet"},{"key":"329_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4161\/cbt.1.1.33","volume":"1","author":"BV Kumar","year":"2002","unstructured":"Kumar BV, Lakhotia S, Ankathil R, Madhavan J: Germline BRCA1 mutation analysis in Indian Breast\/ovarian cancer families. Cancer biology and therapy. 2002, 1: 18-21.","journal-title":"Cancer biology and therapy"},{"key":"329_CR37","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/sj.ejhg.5200988","volume":"11","author":"U Hamann","year":"2003","unstructured":"Hamann U, Liu X, Bungardt N, Ulmar H, Bastert G, Sinn HP: Similar Contributions of BRCAl and BRCA2 germline mutations to early-onset breast cancer in Germany. European J Hum Genet. 2003, 11: 464-467. 10.1038\/sj.ejhg.5200988.","journal-title":"European J Hum Genet"},{"key":"329_CR38","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, Hulick M: Clinical characteristics of individuals with germline mutations in BRCAl and BRCA2: Analysis of 10.000 individuals. J Clin Oncol. 2002, 20: 1480-1490. 10.1200\/JCO.20.6.1480.","journal-title":"J Clin Oncol"},{"key":"329_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/ng0197-103","volume":"15","author":"SA Gayther","year":"1997","unstructured":"Gayther SA, Mangion J, Russell P, Seal S, Barfoot R: Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet. 1997, 15: 103-105. 10.1038\/ng0197-103.","journal-title":"Nat Genet"},{"key":"329_CR40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/ejso.2000.1097","volume":"27","author":"SJ Ramus","year":"2001","unstructured":"Ramus SJ, Fishamn A, Pharoah PD, Yarkoni S, Altaras M, Ponder BA: Ovarian Cancer survival in Ashkenazi Jewish patients with BRCAl and BRCA2 mutations. Eur J Surg Oncol. 2001, 27: 278-281. 10.1053\/ejso.2000.1097.","journal-title":"Eur J Surg Oncol"},{"key":"329_CR41","first-page":"271","volume":"58","author":"S Neuhausen","year":"1996","unstructured":"Neuhausen S, Mazoyer S, Friedman L, Stratton M: Haplotype and Phenotype analaysis of six recurrent BRCA1 mutations in 61 families. Am J Hum Genel. 1996, 58: 271-280.","journal-title":"Am J Hum Genel"},{"key":"329_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/jmg.38.2.102","volume":"38","author":"RB Vander luijt","year":"2001","unstructured":"Vander luijt RB, Avanzon PHA, Jansen RPM: De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer. J Med Genet. 2001, 38: 102-105. 10.1136\/jmg.38.2.102.","journal-title":"J Med Genet"},{"key":"329_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/ng0197-14","volume":"15","author":"SJ Ramus","year":"1997","unstructured":"Ramus SJ, Friedman LS, Gayther SA, Ponder BAJ: A breast\/ovarian patient with germline mutations in both BRCAl and BRCA2. Nat Genet. 1997, 15: 14-15. 10.1038\/ng0197-14.","journal-title":"Nat Genet"},{"key":"329_CR44","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1001\/jama.1993.03500150082032","volume":"269","author":"BB Biesecker","year":"1993","unstructured":"Biesecker BB, Boehnke M, Calzone K, Dorene S: Genetic counseling for families with inherited susceptibility of breast and ovarian cancer. JAMA. 1993, 269: 1970-1974. 10.1001\/jama.269.15.1970.","journal-title":"JAMA"},{"key":"329_CR45","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1086\/301889","volume":"62","author":"A Liede","year":"1998","unstructured":"Liede A, Rehal P, Vesprini D, Jack E, Abrahamson J, Narod SA: A breast cancer patient of Scottish descent with germline mutation in BRCAl and BRCA2. Am J Hum Genet. 1998, 62: 1543-1544. 10.1086\/301889.","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-29-82.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-9966-29-82\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-29-82.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T05:26:11Z","timestamp":1635571571000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-29-82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,25]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["329"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-29-82","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,25]]},"article-number":"82"}}